The CRP levels remained highly elevated during treatment with plasmapheresis averaging 19.2 mg/dL (range 17.4–20.4) while CRP levels were significantly reduced during SCD treatment with an average of 7.4 mg/dL (range 2.7–13.6). This evidence concerns the gene CRP and Schnyder corneal dystrophy.